Andreas Rimner, MD
Open to Accrual
To detect an improvement in overallsurvival with the addition of adjuvant hemithoracic IMPRINT to surgery andchemotherapy compared to surgery and chemotherapy alone.
Patients with pathologically (histologically or cytologically) confirmed diagnosis of epithelioid or biphasic MPM, amenable to MCR, within 90 days prior to Step 1 Registration
We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More
NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.